CA2576556C - Dispositif d'administration de medicaments - Google Patents

Dispositif d'administration de medicaments Download PDF

Info

Publication number
CA2576556C
CA2576556C CA2576556A CA2576556A CA2576556C CA 2576556 C CA2576556 C CA 2576556C CA 2576556 A CA2576556 A CA 2576556A CA 2576556 A CA2576556 A CA 2576556A CA 2576556 C CA2576556 C CA 2576556C
Authority
CA
Canada
Prior art keywords
controlled release
release device
weight
excipient
active pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2576556A
Other languages
English (en)
Other versions
CA2576556A1 (fr
Inventor
Isa Odidi
Amina Odidi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intellipharmaceutics Corp
Original Assignee
Intellipharmaceutics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intellipharmaceutics Corp filed Critical Intellipharmaceutics Corp
Priority to CA2576556A priority Critical patent/CA2576556C/fr
Publication of CA2576556A1 publication Critical patent/CA2576556A1/fr
Application granted granted Critical
Publication of CA2576556C publication Critical patent/CA2576556C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)

Abstract

Un dispositif d'administration de médicament comprenant (a) un ou plusieurs ingrédients pharmaceutiques actifs solubles dans l'eau et/ou un ou plusieurs ingrédients pharmaceutiques actifs insolubles dans l'eau; (b) un ou plusieurs superdésintégrants et/ou un ou plusieurs désintégrants par gonflement; (c) un ou plusieurs polymères solubles dans l'eau et/ou un ou plusieurs polymères insolubles dans l'eau; et (d) un humectant et/ou du tréhalose.
CA2576556A 2007-02-01 2007-02-01 Dispositif d'administration de medicaments Active CA2576556C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA2576556A CA2576556C (fr) 2007-02-01 2007-02-01 Dispositif d'administration de medicaments

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA2576556A CA2576556C (fr) 2007-02-01 2007-02-01 Dispositif d'administration de medicaments

Publications (2)

Publication Number Publication Date
CA2576556A1 CA2576556A1 (fr) 2008-08-01
CA2576556C true CA2576556C (fr) 2014-04-08

Family

ID=39671526

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2576556A Active CA2576556C (fr) 2007-02-01 2007-02-01 Dispositif d'administration de medicaments

Country Status (1)

Country Link
CA (1) CA2576556C (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113116845B (zh) * 2019-12-31 2024-03-19 广州玻思韬控释药业有限公司 胃滞留片

Also Published As

Publication number Publication date
CA2576556A1 (fr) 2008-08-01

Similar Documents

Publication Publication Date Title
US10314787B2 (en) Controlled release delivery device comprising an organosol coat
US20060024361A1 (en) Disintegrant assisted controlled release technology
CA2648278C (fr) Composition d'administration de medicament
US6932983B1 (en) Porous drug matrices and methods of manufacture thereof
US8821938B2 (en) Porous drug matrices and methods of manufacture thereof
KR100883477B1 (ko) 다공성 약물 매트릭스의 약제 조성물
JP2009532389A5 (fr)
US20030175342A1 (en) Coated pharmaceutical single-unit delayed-release forms, based on polyvinyl acetate
KR20090076963A (ko) 당 코팅 및 이의 방법
US10624858B2 (en) Controlled release composition using transition coating, and method of preparing same
CA2576556C (fr) Dispositif d'administration de medicaments
CA2579382C (fr) Dispositif de dispensation a liberation progressive
US20130274352A1 (en) Oral Drug Devices and Drug Formulations

Legal Events

Date Code Title Description
EEER Examination request